Trademarkia Logo

Canada

C$
BEAM THERAPEUTICS
ABANDONED SECTION 36

on 19 Sept 2023

Last Applicant/ Owned by

BEAM THERAPEUTICS INC.

238 Main Street, 9th FloorCambridge MA 02142

US

Serial Number

2012773 filed on 4th Dec 2019

Correspondent Address

DAVIES WARD PHILLIPS & VINEBERG LLP

ATTN: TRADE-MARK DEPARTMENT1501 MCGILL COLLEGE AVENUE26TH FLOORMONTREAL

QUEBEC

CA

H3A3N9

BEAM THERAPEUTICS

Trademark usage description

pharmaceutical and biological preparations based on base correction, base editing, base modification, base repair, nucleobase correction, nucleobase e Read More

Classification Information


Class [005]
Pharmaceutical and biological preparations based on base correction, base editing, base modification, base repair, nucleobase correction, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene correction, gene editing, gene modification, gene modulation, gene repair, gene reprogramming, gene therapy, genome correction, genome editing, genome modification, genome repair, cell therapy, cellular modification, cellular repair, tissue modification, tissue repair, organ modification, and organ repair, for use in human therapeutics.


Classification kind code

11

Class [042]
Scientific and medical research, information, and bioinformatic algorithms and models in the fields of base correction, base editing, base modification, base repair, nucleobase correction, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene correction, gene editing, gene modification, gene modulation, gene repair, gene reprogramming, gene therapy, genome correction, genome editing, genome modification, genome repair, cell therapy, cellular modification, cellular repair, tissue modification, tissue repair, organ modification, and organ repair; scientific study and research in the fields of base correction, base editing, base modification, base repair, nucleobase correction, nucleobase editing, nucleobase modification, nucleobase repair, nucleic acid editing, gene correction, gene editing, gene modification, gene modulation, gene repair, gene reprogramming, gene therapy, genome correction, genome editing, genome modification, genome repair, cell therapy, cellular modification, cellular repair, tissue modification, tissue repair, organ modification, and organ repair to develop human pharmaceutical and biological preparations.


Classification kind code

11

Mark Details


Serial Number

2012773

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 11th May 2021
Search Recorded
Submitted for opposition 20
on 11th May 2021
Examiner's First Report
Submitted for opposition 223
on 11th May 2021
Total Provisional Refusal
Submitted for opposition 256
on 21st Dec 2020
Notification of Possible Opposition Sent
Submitted for opposition 48
on 7th May 2020
Agent Changed
Submitted for opposition 257
on 20th Feb 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 19th Feb 2020
Created
Submitted for opposition 31
on 19th Feb 2020
Formalized
Submitted for opposition 30
on 4th Dec 2019
Filed
Submitted for opposition 228
on 4th Dec 2019
International Registration